Mass Balance Clinical Trial With TEV-56286
Sponsored by Teva Branded Pharmaceutical Products R&D, Inc.
About this trial
Last updated 8 months ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 7 months ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- No major trauma or surgery in the 2 months before screening or at any time between screening and the first dose of the study drug, or surgery scheduled during the clinical trial including the follow-up period. - No history of malignancy or treatment of malignancy in the last 5 years. - No personal or family history of arrhythmia, sudden unexplained death at a young age (before 40 years) in a first-degree relative, or long QT syndrome, or a personal history of syncope of undetermined reason or previous treatment for high blood pressure. NOTE- Additional criteria apply, please contact the investigator for more information
Exclusion Criteria
- History of relevant drug and/or food allergies. - Exposure to radiation for diagnostic reasons (except dental X-rays and plain X-rays of thorax and bony skeleton [excluding spinal column]), during work, or during participation in a clinical trial in the period of 1 year prior to screening. NOTE- Additional criteria apply, please contact the investigator for more information